U.S. FDA approves Mylan generic of Lilly lung cancer drug Alimta - Reuters

U.S. FDA approves Mylan generic of Lilly lung cancer drug Alimta  Reuters

(Reuters) - The U.S. Food and Drug Administration on Thursday granted Mylan NV tentative approval for its generic version of Eli Lilly and Co's lung cancer drug ...



Comments

Popular posts from this blog

Stage 4 Lung Cancer Life Expectancy

Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic ...

Free biotech stocks directory, pharma stocks, telemedicine stocks ...